207 related articles for article (PubMed ID: 34624170)
21.
Chen X; Wang C; Sun N; Pan S; Li R; Li X; Zhao J; Tong H; Tang Y; Han J; Qiao J; Qiu H; Wang H; Yang J; Ikezoe T
Theranostics; 2021; 11(10):4655-4671. PubMed ID: 33754019
[No Abstract] [Full Text] [Related]
22. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
23. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
24. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
25. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.
Jarocha D; Vo KK; Lyde RB; Hayes V; Camire RM; Poncz M
Blood Adv; 2018 Mar; 2(6):597-606. PubMed ID: 29545255
[TBL] [Abstract][Full Text] [Related]
26. Activation of toll-like receptors 2 and 4 on CD34
D'Atri LP; Rodríguez CS; Miguel CP; Pozner RG; Ortiz Wilczyñski JM; Negrotto S; Carrera-Silva EA; Heller PG; Schattner M
J Thromb Haemost; 2019 Dec; 17(12):2196-2210. PubMed ID: 31397069
[TBL] [Abstract][Full Text] [Related]
27. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
28. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
29. Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes.
Nishikii H; Kanazawa Y; Umemoto T; Goltsev Y; Matsuzaki Y; Matsushita K; Yamato M; Nolan GP; Negrin R; Chiba S
Stem Cells; 2015 Jul; 33(7):2196-207. PubMed ID: 25753067
[TBL] [Abstract][Full Text] [Related]
30. FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.
Vo KK; Jarocha DJ; Lyde RB; Hayes V; Thom CS; Sullivan SK; French DL; Poncz M
Blood; 2017 Jun; 129(26):3486-3494. PubMed ID: 28432223
[TBL] [Abstract][Full Text] [Related]
31. Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production.
Krisch L; Brachtl G; Hochmann S; Andrade AC; Oeller M; Ebner-Peking P; Schallmoser K; Strunk D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360992
[TBL] [Abstract][Full Text] [Related]
32. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
34. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis.
Song H; Li J; Peng C; Liu D; Mei Z; Yang Z; Tian X; Zhang X; Jing Q; Yan C; Han Y
Int J Biol Sci; 2023; 19(11):3614-3627. PubMed ID: 37496998
[TBL] [Abstract][Full Text] [Related]
35. Dual role of IL-21 in megakaryopoiesis and platelet homeostasis.
Benbarche S; Strassel C; Angénieux C; Mallo L; Freund M; Gachet C; Lanza F; de la Salle H
Haematologica; 2017 Apr; 102(4):637-646. PubMed ID: 28057742
[TBL] [Abstract][Full Text] [Related]
36. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
de Sauvage FJ; Carver-Moore K; Luoh SM; Ryan A; Dowd M; Eaton DL; Moore MW
J Exp Med; 1996 Feb; 183(2):651-6. PubMed ID: 8627177
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway.
Ye JY; Chan GC; Qiao L; Lian Q; Meng FY; Luo XQ; Khachigian LM; Ma M; Deng R; Chen JL; Chong BH; Yang M
Haematologica; 2010 Oct; 95(10):1745-53. PubMed ID: 20562316
[TBL] [Abstract][Full Text] [Related]
38. [Factor analysis of effective platelet-producing ability of fetal liver-derived cells].
Yu MR; Yang GH; Liu GH; Zeng YT; Xue Y; Ma QW; Zeng FY
Zhonghua Nei Ke Za Zhi; 2022 Jun; 61(6):664-672. PubMed ID: 35673747
[No Abstract] [Full Text] [Related]
39. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
40. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
